Avivagen Revenue and Competitors
Estimated Revenue & Valuation
- Avivagen's estimated annual revenue is currently $697.5k per year.
- Avivagen's estimated revenue per employee is $77,500
Employee Data
- Avivagen has 9 Employees.
- Avivagen grew their employee count by -18% last year.
Avivagen's People
Name | Title | Email/Phone |
---|---|---|
1 | Chair and CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | Director Commercialization Science | Reveal Email/Phone |
4 | Director Investor Relations | Reveal Email/Phone |
5 | Director Logistics Operations | Reveal Email/Phone |
6 | Marketing Manager | Reveal Email/Phone |
7 | Chairman & CEO | Reveal Email/Phone |
8 | Chairman the Board Directors | Reveal Email/Phone |
9 | Dir Product Validation | Reveal Email/Phone |
10 | N/A | Reveal Email/Phone |
Avivagen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Avivagen?
Avivagen Inc. is a publicly-listed life sciences company trading on the TSX Venture Exchange under the ticker symbol “VIV” and OTC Pink under the ticker symbol “CHEXF.” The Company’s goal is to develop and deliver scientifically-proven solutions that can truly benefit companion and production animals by employing natural mechanisms for maintaining good health. Targeted markets include Livestock Productivity and Pet Wellness.
keywords:N/AN/A
Total Funding
9
Number of Employees
$697.5k
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $0.7M | 9 | -25% | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.6M | 9 | N/A | N/A |